Search clinical trials for: Type 2 Diabetes Mellitus, T2DM, GLP-1, GLP-1 Once weekly, Exenatide
Total 130282 results
-
University of BathArla FoodsCompletedGLP-1 ConcentrationUnited Kingdom
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedGut Microbiota | GLP-1Mexico
-
Adrian VellaCompletedPancreatic Effects of 9,39-Exendin and 9,36-GLP-1United States
-
Rigshospitalet, DenmarkDepartment of Cardiovascular and Renal Research, University of Southern DenmarkCompleted
-
Third Military Medical UniversityUnknownGLP-1；Metformin；Telomere-telomerase System；Par-4China
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Australia, United Kingdom, Mexico, Argentina, Brazil, Israel, Canada
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; Merck Sharp & Dohme LLCCompletedHyperglycemiaGermany
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
Dasman Diabetes InstituteRecruitingDiabetes Mellitus, Type 2Kuwait
-
Zealand PharmaProfil Institut für Stoffwechselforschung GmbHRecruitingSafety and TolerabilityGermany
-
University of CopenhagenGentofte Hospital, DenmarkRecruiting
-
Eli Lilly and CompanyActive, not recruitingGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2DUnited States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
-
University of Maryland, BaltimoreActive, not recruiting
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Romania, Ukraine, Germany, Italy, Estonia, Malaysia, Philippines, Mexico, Lithuania, Colombia, Slovakia, Chile
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
-
Zealand PharmaCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2India
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Type 2 Diabetes MellitusUnited States
-
SanofiCompletedDiabetes Mellitus Type 2United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
-
Hvidovre University HospitalUnknown
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknownThe Focus of This Study is to Evaluete the Significances of the Vagal Cholinerg Nervuos System for the Effect of GLP-1 by Using Atropin Administration.Denmark
-
University Hospital, Gentofte, CopenhagenCompletedObesity | Type 2 Diabetes | AdiposityDenmark
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
University of PadovaAzienda Ospedaliera di PadovaUnknown
-
Herlev HospitalUniversity of Copenhagen; The Danish Medical Research Council; The Danish Diabetes...Completed
-
SanofiCompleted
-
Hvidovre University HospitalCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Japan, India, Puerto Rico, Mexico
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Hangzhou Sciwind Biosciences Co., Ltd.Active, not recruitingType 2 Diabetes Mellitus | T2DMChina
-
Albany College of Pharmacy and Health SciencesCompletedType 2 Diabetes Mellitus
-
University of CopenhagenHvidovre University HospitalCompletedType2 DiabetesDenmark
-
University of Mississippi Medical CenterRecruitingDiabetes Mellitus, Type 2 | Osteoporosis, PostmenopausalUnited States
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterCompleted
-
Hangzhou Sciwind Biosciences Co., Ltd.Active, not recruitingType 2 Diabetes Mellitus | T2DMChina
-
University of AarhusCompleted
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Germany, Argentina, Brazil, Turkey, Hungary, Italy, Russian Federation, Slovakia, Belgium, Czechia, Greece, Mexico, Romania
-
National University, SingaporeNational University Health SystemCompleted
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
SanofiCompletedDiabetes Mellitus, Type 2United States, France, Canada, Brazil, Russian Federation, Germany, Italy, Turkey, India, Mexico, Egypt, United Kingdom, Korea, Republic of, Chile, Puerto Rico
-
PfizerTerminatedDiabetes Mellitus, Type 2United States
-
Kowa Company, Ltd.SanofiCompleted
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Japan, Germany, Czechia, Poland, Slovakia
-
Radboud University Medical CenterRijnstate HospitalRecruiting